News

Novo Nordisk's popular weight-loss and diabetes drugs Wegovy and Ozempic may in very rare cases cause a serious eye condition ...
The European Medicines Agency warns that Novo Nordisk's Ozempic and Wegovy may, in rare cases, cause NAION—a serious eye condition that can lead to vision loss. The EMA has asked the company to update ...
Body image is part physical and part mental. If weight loss alone isn't helping, strategies from body image psychology can ...
Weight-loss drugs are already dropping in price; could they go even lower? - Consumers are now able to pay roughly $500 for ...
The Indianapolis-based drugmaker sees orforglipron as a potential global breakthrough treatment for weight loss and other ...
Omada Health shares climbed after the company made its debut on Nasdaq. The virtual healthcare company started trading shares at $19 on Friday morning, and they jumped 35% to $25.58 by midday. It ...
A new study brings into focus the relationship between diabetic GLP-1 users and the elevated risk of age-related eye disease.
I've been a Novo Nordisk bull for quite some time now, and I wouldn't be as spooked by the situation. Here's why. Novo Nordisk got a two-year-plus head start in the white-hot obesity drugs market, ...
Health experts are raising concerns for women using popular weight loss medications, particularly GLP-1s like Wegovy, ...
Also: A Medicare crisis and doctors’ concerns with Kennedy’s new coronavirus vaccine policy.
Apple cider vinegar can cause side effects when taking it and certain medications. Learn which medications apple cider ...
THURSDAY, June 5, 2025 (HealthDay News) — More American teenagers now use the weight-loss drug Wegovy, as doctors and ...